These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26549344)

  • 41. Integrated transcriptomic and epigenomic analysis of ovarian cancer reveals epigenetically silenced GULP1.
    Maldonado L; Brait M; Izumchenko E; Begum S; Chatterjee A; Sen T; Loyo M; Barbosa A; Poeta ML; Makarev E; Zhavoronkov A; Fazio VM; Angioli R; Rabitti C; Ongenaert M; Van Criekinge W; Noordhuis MG; de Graeff P; Wisman GBA; van der Zee AGJ; Hoque MO
    Cancer Lett; 2018 Oct; 433():242-251. PubMed ID: 29964205
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Spheroid growth in ovarian cancer alters transcriptome responses for stress pathways and epigenetic responses.
    Paullin T; Powell C; Menzie C; Hill R; Cheng F; Martyniuk CJ; Westerheide SD
    PLoS One; 2017; 12(8):e0182930. PubMed ID: 28793334
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypermethylation of tumor suppressor genes is a risk factor for poor prognosis in ovarian cancer: A meta-analysis.
    Feng LY; Chen CX; Li L
    Medicine (Baltimore); 2019 Feb; 98(8):e14588. PubMed ID: 30813180
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current data and future perspectives on DNA methylation in ovarian cancer (Review).
    Fu M; Deng F; Chen J; Fu L; Lei J; Xu T; Chen Y; Zhou J; Gao Q; Ding H
    Int J Oncol; 2024 Jun; 64(6):. PubMed ID: 38757340
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gene methylation of human ovarian carcinoma stromal progenitor cells promotes tumorigenesis.
    Ho CM; Shih DT; Hsiao CC; Huang SH; Chang SF; Cheng WF
    J Transl Med; 2015 Nov; 13():367. PubMed ID: 26597084
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of candidate epigenetic biomarkers for ovarian cancer detection.
    Huang YW; Jansen RA; Fabbri E; Potter D; Liyanarachchi S; Chan MW; Liu JC; Crijns AP; Brown R; Nephew KP; van der Zee AG; Cohn DE; Yan PS; Huang TH; Lin HJ
    Oncol Rep; 2009 Oct; 22(4):853-61. PubMed ID: 19724865
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Integrated multiomic predictors for ovarian cancer survival.
    Fu A; Chang HR; Zhang ZF
    Carcinogenesis; 2018 Jul; 39(7):860-868. PubMed ID: 29897425
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A new approach to epithelial-mesenchymal transition diagnostics in epithelial tumors: double immunofluorescent staining and flow cytometry.
    Bogush TA; Basharina AA; Eliseeva BK; Kaliuzhny SA; Bogush EA; Kirsanov VY; Davydov MM; Kosorukov VS
    Biotechniques; 2020 Oct; 69(4):257-263. PubMed ID: 32777933
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cancer-testis antigens in ovarian cancer: implication for biomarkers and therapeutic targets.
    Xie K; Fu C; Wang S; Xu H; Liu S; Shao Y; Gong Z; Wu X; Xu B; Han J; Xu J; Xu P; Jia X; Wu J
    J Ovarian Res; 2019 Jan; 12(1):1. PubMed ID: 30609934
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of ACAP1 Is Associated with Tumor Immune Infiltration and Clinical Outcome of Ovarian Cancer.
    Zhang J; Zhang Q; Zhang J; Wang Q
    DNA Cell Biol; 2020 Sep; 39(9):1545-1557. PubMed ID: 32456571
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical implications of epigenetic regulation in oral cancer.
    D'Souza W; Saranath D
    Oral Oncol; 2015 Dec; 51(12):1061-8. PubMed ID: 26421863
    [TBL] [Abstract][Full Text] [Related]  

  • 52. UCP1 modulates immune infiltration level and survival outcome in ovarian cancer patients.
    Huang J; Wang G; Liao K; Xie N; Deng K
    J Ovarian Res; 2022 Jan; 15(1):16. PubMed ID: 35090503
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of DNA De-methylation intermediate '5-hydroxymethylcytosine' in ovarian cancer management: A comprehensive review.
    Bisht D; Arora A; Sachan M
    Biomed Pharmacother; 2022 Nov; 155():113674. PubMed ID: 36099791
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The impact of DNA methylation on the cancer proteome.
    Magzoub MM; Prunello M; Brennan K; Gevaert O
    PLoS Comput Biol; 2019 Jul; 15(7):e1007245. PubMed ID: 31356589
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epigenetic alterations of the Wnt signaling pathway in cancer: a mini review.
    Serman L; Nikuseva Martic T; Serman A; Vranic S
    Bosn J Basic Med Sci; 2014 Nov; 14(4):191-4. PubMed ID: 25428669
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epigenetics in ovarian cancer.
    Natanzon Y; Goode EL; Cunningham JM
    Semin Cancer Biol; 2018 Aug; 51():160-169. PubMed ID: 28782606
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overexpression of SYNGAP1 suppresses the proliferation of rectal adenocarcinoma via Wnt/β-Catenin signaling pathway.
    Xiao Y; Zhu Y; Chen J; Wu M; Wang L; Su L; Feng F; Hou Y
    Discov Oncol; 2024 Apr; 15(1):135. PubMed ID: 38679635
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epigenetic markers of ovarian cancer.
    Barton CA; Clark SJ; Hacker NF; O'Brien PM
    Adv Exp Med Biol; 2008; 622():35-51. PubMed ID: 18546617
    [No Abstract]   [Full Text] [Related]  

  • 59. Wnt antagonist as therapeutic targets in ovarian cancer.
    Y KN; Perumalsamy NK; Warrier S; Perumalsamy LR; Dharmarajan A
    Int J Biochem Cell Biol; 2022 Apr; 145():106191. PubMed ID: 35272015
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overview of the signaling pathways involved in metastasis: An intriguing story-tale of the metastatic journey of ovarian cancer cells.
    Attar R; Panah T; Romero MA; Yulaevna IM; Gazouli M; Berardi R; Wieczorek E; Farooqi AA
    Cell Mol Biol (Noisy-le-grand); 2021 Nov; 67(3):212-223. PubMed ID: 34933706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.